Blaschkitis under certolizumab for rheumatoid arthritis.
Rheumatology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France. Electronic address: mcouderc@chu-clermontferrand.fr.
Marion
M
Couderc
Rheumatology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Martin
M
Soubrier
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068582:Certolizumab Pegol; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*
D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D007166:Immunosuppressive Agents; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol
Blaschkitis; Blaschko's lines; Certolizumab; Linear dermatoses; Rheumatoid arthritis; TNF-α blockers